Finance

Beta
Lists
688526:SHA
Wuhan Keqian Biology Co Ltd
CN¥12.36
0.00%
(0.00) 1D
Jun 10, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688526...
Open
CN¥12.21
High
CN¥12.42
Low
CN¥12.21
Mkt. cap
5.76B
Avg. vol.
1.47M
Volume
836.29K
Dividend
5.18%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
14.77
52-wk high
CN¥20.39
52-wk low
CN¥12.11
EPS
CN¥0.84
No. of employees
950
Open
CN¥12.21
High
CN¥12.42
Low
CN¥12.21
Mkt. cap
5.76B
Avg. vol.
1.47M
Volume
836.29K
Dividend
5.18%
Quarterly dividend
CN¥0.16
Ex-dividend date
May 26, 2026
P/E ratio
14.77
52-wk high
CN¥20.39
52-wk low
CN¥12.11
EPS
CN¥0.84
No. of employees
950
News stories
From sources across the web
About Wuhan Keqian Biology Co Ltd
CEO-
Employees950
FoundedJan 11, 2001
Headquarters-
SectorPharmaceutical industry
Websitekqbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
242.10M
250.57M
211.88M
227.54M
Cost of goods sold
78.36M
81.77M
86.92M
81.91M
Cost of revenue
78.36M
81.77M
86.92M
81.91M
Research and development expenses
24.17M
26.38M
24.54M
25.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.48M
45.53M
35.58M
35.67M
Operating expense
70.47M
34.92M
89.78M
57.03M
Total operating expenses
148.82M
116.68M
176.70M
138.94M
Operating income
93.28M
133.89M
35.18M
88.60M
Other non operating income
-280.93K
-717.89K
2.18M
3.30M
EBT including unusual items
128.08M
135.40M
92.57M
90.10M
EBT excluding unusual items
111.33M
143.50M
55.13M
94.05M
Income tax expense
16.59M
18.07M
12.23M
11.42M
Effective tax rate
12.95%
13.35%
13.21%
12.67%
Other operating expenses
851.18K
-9.53M
11.28M
-3.75M
Net income
111.66M
117.90M
80.93M
79.24M
Net profit margin
46.12%
47.05%
38.20%
34.82%
Earnings per share
-
-
-
-
Interest and investment income
18.40M
10.45M
18.66M
2.15M
Interest expense
-72.07K
-122.12K
-
-
Net interest expenses
18.33M
10.33M
18.66M
2.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
121.10M
160.94M
63.12M
116.54M
Gain or loss from assets sale
-
-
6.90M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer